Lithium shows reversal in memory loss, OneSkin nabs $20M, and the Human Phenotype Project rolls on.
The science behind organ aging, and when to take action. All that and more in this edition.
Our review of Bearmore, the wellness app building trust, and a special sitdown with founder Aulay Macaulay.
7,000 steps a day, NOVOS debuts all-in-one bar, and you can now track your sun exposure via an app. All that and more in this edition.
Loyal study hits full enrollment, Ultrahuman marries blood testing with wearables, and Bryan Johnson mulls a change at Blueprint.
The fungi study that's turning heads, and SOLO brings new meaning to all-in-one. All that and more in this edition.
Inside the science behind tennis, longevity retreats are the new beach vacation, and our pets are now on the verge of stem cell therapies. All that and more in this edition.
The whacky world of Dave Asprey's biohacking conference, and RFK hops on the wearables trend. All that and more in this edition.
Magnesium topicals for sleep, a closer look at sea moss, and the future of anti-aging may exist in the diabetes space already. All that and more in this edition.
AG1 copycats are popping up like wildfire, Acer enters the smart-ring category, and swapping out your American breakfast for a Blue-zone inspired one may be an easy hack. All that and more in this edition.
Taurine flops in major human trial, coffee shows lifespan boost for middle-aged women, and a modern nutrition theory gets more supporting data. All that and more in this edition.
Breakthrough in human plasma trial, cancer-drug combo shows promise, and Bryan Johnson's wearable company is ready for the big stage. All that and more in this week's edition.
Creatine vs. Alzheimer's, Vitamin D shows anti-aging promise, and pecorino cheese may be a superfood. All that and more in this week's edition.
Montana opens the floodgates to experimental drugs, 23andMe lives on, and we share a deep dive on whey vs. plant protein. All that and more in this week's edition.
WHOOP 5.0 hits shelves, Oura ring expands toolkit, and the longevity economy is flooding with funding. All that and more in this week's edition.
Science-backed reasons you should be consuming more olive oil, Unity Biotech goes bust, and AG1 touts their latest clinical trials. All that and more in this week's edition.
